100 filings
Page 4 of 5
8-K
68l11nzwo6
26 May 21
Departure of Directors or Certain Officers
4:30pm
8-K
wyc9sjv32 3yadge
13 May 21
Metacrine Accelerates MET409 Clinical Development Milestone and Reports First-Quarter 2021 Results
4:10pm
DEFA14A
gkmtqr ui8zkv
9 Apr 21
Additional proxy soliciting materials
4:10pm
DEF 14A
22gzpwo7 b0sq4ru8t
9 Apr 21
Definitive proxy
4:05pm
8-K
9ir78v
5 Apr 21
Metacrine Appoints Dr. Julia C. Owens to its Board of Directors
4:10pm
10-K
wuez4fl5u2uhon
18 Mar 21
Annual report
4:32pm
8-K
anz7gdh5kk9we7lwtk
18 Mar 21
Metacrine Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
6:35am
8-K
veolkmt2vc2mmi
12 Feb 21
Results of Operations and Financial Condition
4:30pm
10-Q
qxjta1e nnziu0
12 Nov 20
Quarterly report
6:41am
8-K
28uiy1h7m g197v
12 Nov 20
Metacrine Reports Business Updates and Third Quarter 2020 Financial Results
6:36am
S-8
vca kmpk7qmlu1
23 Sep 20
Registration of securities for employees
4:59pm
8-K
jflvwopzqtrnvhkh0
18 Sep 20
Amendments to Articles of Incorporation or Bylaws
5:23pm
424B4
dbqk gyhbm
16 Sep 20
Prospectus supplement with pricing info
4:01pm
CERT
h9anv hoa
16 Sep 20
Certification of approval for exchange listing
10:52am
EFFECT
qakl79levm
16 Sep 20
Notice of effectiveness
12:15am
CORRESP
96mqy
14 Sep 20
Correspondence with SEC
12:00am
UPLOAD
zwpili9s
14 Sep 20
Letter from SEC
12:00am
8-A12B
f9pszpot
11 Sep 20
Registration of securities on exchange
4:50pm